Anti-Tau (phospho S199) antibody [EPR2401Y]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
4
(2 Reviews)
|
(22 Publications)
Rabbit Recombinant Monoclonal TAU phospho S199 antibody. Suitable for Dot, WB and reacts with Synthetic peptide, Mouse, Human samples. Cited in 22 publications.
View Alternative Names
MAPTL, MTBT1, TAU, MAPT, Microtubule-associated protein tau, Neurofibrillary tangle protein, Paired helical filament-tau, PHF-tau
- WB
Lab
Western blot - Anti-Tau (phospho S199) antibody [EPR2401Y] (AB81268)
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Tau (phospho S199) antibody [EPR2401Y] (ab81268) at 1/1000 dilution
Lane 1:
293T cells transfected with an empty vector containing a flag tag whole cell lysate at 20 µg
Lane 2:
293T cells transfected with a human Tau expression vector containing a flag whole cell lysate at 20 µg
Lane 3:
293T cells transfected with a human MAP2 expression vector containing a flag whole cell lysate at 20 µg
Lane 4:
293T cells transfected with a human MAP4 expression vector containing a flag whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 78 kDa
Observed band size: 55-100 kDa
false
Exposure time: 1s
- WB
Lab
Western blot - Anti-Tau (phospho S199) antibody [EPR2401Y] (AB81268)
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Tau (phospho S199) antibody [EPR2401Y] (ab81268) at 1/1000 dilution
Lane 1:
Human hippocampus tissue lysate at 10 µg
Lane 2:
Human hippocampus tissue lysate. The membrane was incubated with phosphatase at 10 µg
Secondary
All lanes:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/2000 dilution
Predicted band size: 78 kDa
Observed band size: 55 kDa
false
Exposure time: 1min
- WB
Supplier Data
Western blot - Anti-Tau (phospho S199) antibody [EPR2401Y] (AB81268)
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Tau (phospho S199) antibody [EPR2401Y] (ab81268) at 1/1000 dilution
Lane 1:
Mouse cerebral cortex tissue lysate at 10 µg
Lane 2:
Mouse cerebral cortex tissue lysate, The membrane was incubated with phosphatase at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 78 kDa
Observed band size: 55 kDa
false
Exposure time: 5s
- WB
Unknown
Western blot - Anti-Tau (phospho S199) antibody [EPR2401Y] (AB81268)
All lanes:
Western blot - Anti-Tau (phospho S199) antibody [EPR2401Y] (ab81268) at 1/20000 dilution
Lane 1:
SH SY5Y cell lysate at 10 µg
Lane 2:
SH SY5Y cell lysate treated with alkaline phosphatase at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 78 kDa
Observed band size: 55 kDa
false
- Dot
Unknown
Dot Blot - Anti-Tau (phospho S199) antibody [EPR2401Y] (AB81268)
Dot blot analysis of Tau (pS199) peptide (Lane 1) and Tau non-phospho peptide (Lane 2) labelling Tau (pS199) with ab81268 at a dilution of 1/1000. ab97051 (peroxidase-conjugated goat anti-rabbit IgG (H+L)) was used as the secondary antibody at a dilution of 1/100000.
Exposure time : 3 minutes.
Blocking and dilution buffer : 5% NFDM/TBST.
- Dot
Supplier Data
Dot Blot - Anti-Tau (phospho S199) antibody [EPR2401Y] (AB81268)
Dot blot analysis using 1/1000 dilution ab81268 and Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) secondary at 1/100000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST
Lane 1 : Tau non-phospho peptide
Lane 2 : Tau S199 phospho peptide
Lane 3 : Tau S202 phospho peptide
Lane 4 : Tau S199+S202 phospho peptide
Exposure time : 3 minutes
- WB
CiteAb
Western blot - Anti-Tau (phospho S199) antibody [EPR2401Y] (AB81268)
Tau (phospho S199) western blot using anti-Tau (phospho S199) antibody [EPR2401Y] ab81268. Publication image and figure legend from Yang, S. H., Lee, D. K., et al., 2017, EMBO Mol Med, PubMed 27861127.
ab81268 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab81268 please see the product overview.
Nec‐1 inhibits the phosphorylation and aggregation of tauAWestern blot analysis of phosphorylation levels of tau and expression levels of indicated proteins in the cortical and hippocampal regions of the brain in APP/PS1 mice after administration of Nec‐1 (6.25 mg/kg) or vehicle (2.5% DMSO in PBS). The membranes analysed are identical to those in Fig 5F.BImmunohistochemical analysis of cortical and hippocampal regions of the brains in wild‐type (Wt) and APP/PS1 mice after administration of Nec‐1 (6.25 mg/kg) or vehicle (2.5% DMSO in PBS) for phosphorylated tau expression levels. Anti‐tau (phospho‐Ser199) antibody (red colour) was applied for staining tau phosphorylation on serine‐199 and Hoechst 33342 (blue colour) for nuclear counterstaining in the brain sections. Scale bars = 200 μm. Yellow and red boxes indicate the cortical and hippocampal region of brains, respectively.CWestern blot analyses of phosphorylated RIPK3 expression in cortex and hippocampus of APP/PS1 mice injected with Nec‐1 (upper), and primary cultured astrocytes treated with Nec‐1 (lower). The membranes analysed are identical to those in Figs 1G and 5F.D, EThT assays for the inhibition of tau aggregation (D) and for disaggregation of tau (E). Fluorescence intensity was normalized to tau aggregates (100%, day 5). All data are representative results of at least three independent experiments.FSurface plasmon resonance sensorgrams of Nec‐1 targeting tau (left), and the corresponding dissociation fitting curve from the saturated region (right) under various concentrations of Nec‐1.Data information : In (D and E), data are presented as mean ± SEM. ***P ≤ 0.001 (one‐way ANOVA followed by Bonferroni's post hoc comparisons tests). Exact P‐values are shown in Table EV5. Source data are available online for this figure.
false
Related conjugates and formulations (1)
-
Anti-Tau (phospho S199) antibody [EPR2401Y] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Tau is involved in the assembly and stabilization of microtubules essential for maintaining neuronal structure. It interacts with microtubule-binding domains (MBD) to bind and bundle microtubules facilitating intracellular transport. Tau forms a part of the neuronal cytoskeleton complex working closely with other cytoskeletal proteins to preserve the proper axonal transport and function. Abnormally phosphorylated Tau often termed phospho-Tau disrupts this complex affecting microtubule stability.
Pathways
Tau has critical involvement in several signaling cascades such as the microtubule-binding and transport pathways. Glycogen synthase kinase 3 beta (GSK3β) and cyclin-dependent kinase 5 (CDK5) frequently phosphorylate Tau controlling its interaction with microtubules. Phosphorylated Tau accumulates leading to the formation of neurofibrillary tangles often observed in neurodegenerative conditions. Additionally Tau interacts with GAPDH impacting cellular energy regulation through potential pathway cross-talk involving oxidative stress responses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (22)
Recent publications for all applications. Explore the full list and refine your search
Neurotrauma reports 6:586-599 PubMed40933834
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell communication and signaling : CCS 23:7 PubMed39762888
2025
Applications
Unspecified application
Species
Unspecified reactive species
Zoological research 46:41-53 PubMed39757019
2025
Applications
Unspecified application
Species
Unspecified reactive species
Acta neuropathologica 148:46 PubMed39316141
2024
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicines 12: PubMed39200168
2024
Applications
Unspecified application
Species
Unspecified reactive species
Acta neuropathologica 147:87 PubMed38761203
2024
Applications
Unspecified application
Species
Unspecified reactive species
Phytotherapy research : PTR 37:4771-4790 PubMed37434441
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 41:111580 PubMed36323248
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of Alzheimer's disease : JAD 77:149-163 PubMed32804126
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of integrative neuroscience 18:309-312 PubMed31601081
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com